3-hydroxyflavone has been researched along with cyclin d1 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Choi, J; Park, S | 1 |
Abdelhameed, MF; Afifi, NA; El-Eraky, W; El-Fadaly, AA; El-Rahman, SSA; Ramadan, A; Salama, A | 1 |
2 other study(ies) available for 3-hydroxyflavone and cyclin d1
Article | Year |
---|---|
Inhibition of beta-catenin/Tcf signaling by flavonoids.
Topics: Axin Protein; beta Catenin; Blotting, Western; Cell Line; Cell Line, Tumor; Cyclin D1; Cytoskeletal Proteins; Flavanones; Flavonoids; Flavonols; Gene Expression; Genistein; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Kaempferols; Mutation; Phosphorylation; Protein Binding; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Quercetin; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; TCF Transcription Factors | 2010 |
Fisetin alleviates thioacetamide-induced hepatic fibrosis in rats by inhibiting Wnt/β-catenin signaling pathway.
Topics: Animals; beta Catenin; Biomarkers; Cyclin D1; Flavonols; Glycogen Synthase Kinase 3 beta; Hepatic Stellate Cells; Liver; Liver Cirrhosis; Matrix Metalloproteinase 9; Rats; Silymarin; Thioacetamide; Tissue Inhibitor of Metalloproteinase-1; Wnt Signaling Pathway | 2022 |